Navigation Links
FDA Agrees to Amend Dendreon's Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE
Date:3/12/2008

ne million men in the United States have prostate cancer, with an estimated 186,320 new cases expected to be diagnosed in 2008, and approximately 28,660 men expected to die this year from the disease. Currently there are limited treatment options for men with advanced, metastatic prostate cancer.

About Active Cellular Immunotherapy with PROVENGE

PROVENGE may represent the first product in a new class of active cellular immunotherapies (ACIs) that are uniquely designed to use live human cells to engage the patient's own immune system with the goal of eliciting a specific long-lasting response against cancer. In clinical studies, patients typically received three doses of PROVENGE over a one-month period as a complete course of therapy.

About Dendreon

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response. Active cellular immunotherapy holds promise because it may provide patients with a meaningful clinical benefit, such as survival, combined with low toxicity. The Company has its headquarters in Seattle, Washington and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit http://www.dendreon.com.

Except for historical information contained herein, this news release contains forward-looking statements that are subject to risks and uncertainties surrounding the efficacy of PROVENGE to treat men suffering from prostate cancer, risks and uncertainties surrounding the presentation of data to the FDA and approval of product applications by the FDA and risks
'/>"/>

SOURCE Dendreon Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. FDA Agrees to Review Cimzia(R) File for the Treatment of Rheumatoid Arthritis
2. Inverness Medical Innovations Agrees to Acquire ParadigmHealth
3. Inverness Medical Innovations Agrees to Acquire Panbio Ltd.
4. Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement
5. Mylan Announces Amendment to Bystolic(TM) (Nebivolol) Agreement
6. Neurobiological Technologies Announces Amendment of License and Cooperation Agreement with Merz Pharmaceuticals and Childrens Hospital
7. Barr Confirms Patent Challenge of Namenda(R) Tablets, 5mg & 10mg
8. ExonHit and bioMerieux Amend Their Strategic Partnership
9. Halozyme Therapeutics Amends Stockholder Rights Plan
10. Beanstalk Capital Ltd. and iCo Therapeutics Inc. amend arrangement agreement
11. Genmab Amends HuMax-CD4 Pivotal Study in CTCL
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013 Patheon Inc ., a ... the global pharmaceutical industry, will host a complimentary webinar ... Testing” on Tuesday, June 4, 2013 at 11 a.m. ... required to comply with regulations for cleaning validation. ... scientific underpinning and little evaluation of risk. Some ...
(Date:5/23/2013)... May 23, 2013 VG Energy, an ... with DAK Renewable Research to conduct field trials ... VG Energy is a majority owned subsidiary of ... VG Energy,s exclusively licensed compound LipidMax selectively ... yield in plants, possessing a wide variety of ...
(Date:5/23/2013)... 2013 Z Trim Holdings, Inc. (OTC Markets: ... variety of industries, announced that Chef Erin ... this year,s National Restaurant Association ("NRA") NRA Show, which ... the Research Chefs Association.  Chef Ryan spoke on the ... Bad and the Ugly," joining four other prestigious panelists ...
(Date:5/23/2013)... 23, 2013 During the conduct ... to adhere to principles of good clinical practice ... speaker Dr. Jeremy Lim, Fellow, Clinical Development at ... ,     Understand the International Conference on Harmonization ... additional regulations for the conduction of clinical trials ...
Breaking Biology Technology:Patheon to Present on “Cleaning Validation: Science, Risk and Novel Approaches to Testing” 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 3Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 2Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 3Adhering to Good Clinical Practice, New Webinar Hosted by Xtalks 2
... Inc. (Nasdaq: ALXA ) announced today the company,s,participation and that Thomas ... in September., Conference: NewsMakers in the ... Hotel & Conference Center ... Street, New York Presentation Date: Thursday, September 4, 2008 ...
... Last ... ... premier,provider of economical ultrasound solutions, today announced it has,installed its 1000th ... year. Recent installations include Norwegian,American Hospital in Chicago, Women,s Center for ...
... year of The Kavli Prize will be celebrated with a ... the prize to the seven Kavli laureates. Acclaimed scientists in ... throughout the week. , , Note: The award ceremony, lectures and ... briefing at 11.15 AM (CET), September 9, in Oslo Concert ...
Cached Biology Technology:Alexza Pharmaceuticals Announces Upcoming Webcasts and Conference Participation 2Alexza Pharmaceuticals Announces Upcoming Webcasts and Conference Participation 3MedPro Installs 1000th Ultrasound System Worldwide 2Inaugural Kavli Prize ceremony and symposia: Sept. 8-11 (Oslo, Norway) 2Inaugural Kavli Prize ceremony and symposia: Sept. 8-11 (Oslo, Norway) 3
(Date:5/22/2013)... CITY, May 22, 2013 U.S. Forest Service scientists ... that, with funding from the TKF Foundation, will examine ... communities and individuals recover from tragedy. , The TKF ... of six projects selected for grant funding. In addition ... sacred spaces in recovery and resiliency, the 3-year, $585,000 ...
(Date:5/22/2013)... omega 3 fatty acids in fish oil have long ... that the American Heart Association currently recommends eating at ... varieties rich in omega 3s. However, the mechanism behind ... new study, scientists led by Jason R. Carter of ... providing evidence that fish oil might specifically counteract the ...
(Date:5/22/2013)... details on how climate change will affect interactions between ... Journal of Animal Ecology . This knowledge, they ... policymakers of how species are likely to be impacted ... growing recognition among biologists that climate change is affecting ... is going to have very important consequences for the ...
Breaking Biology News(10 mins):'Landscapes of Resilience' to study how people use nature as a source of recovery 2Fish oil may help the heart beat mental stress 2UCLA life scientists present new insights on climate change and species interactions 2UCLA life scientists present new insights on climate change and species interactions 3UCLA life scientists present new insights on climate change and species interactions 4UCLA life scientists present new insights on climate change and species interactions 5
... al.report in the Journal of Cell Biology ... movement in tumor cells., On 2D surfaces, cells may ... the cell to the extracellular matrix, are known to ... been unclear. Recent work has suggested that an integrin ...
... JOLLA, CAIf the current financial climate has taught us anything, ... in disaster. It turns out this rule applies as much ... cash, our body deals in energy borrowed from muscle and ... lending process in the body is under strict regulation to ...
... New Sales Executives to Focus on Top 100 ... Kount Inc. ( http://www.kount.com ),a leading provider of ... Scott Lewer and Brad Canavan as National Account ... amount of,industry knowledge and experience in ecommerce fraud ...
Cached Biology News:Food for thought -- regulating energy supply to the brain during fasting 2Food for thought -- regulating energy supply to the brain during fasting 3Kount Lands Veteran Fraud Experts From Retail Decisions and iovation 2
Tris-Hepes kit of BG-163 & BG-165 (order number BG-166)...
... ZMD.326. Immunogen: Synthetic peptide derived ... human WNT1 protein. Specificity: Reacts ... proteins. Reactivity: Human Mouse (positive ... SW480 cell lysates and mouse Mouse-1 ...
... new StrepMAB-Immo coated microplates can be used ... SerAla-Strep-tag II fusion proteins for ELISA or ... amounts of such proteins are bound with ... on the left) and will not elute ...
ABI 432 Resins • Gln(Trt) Peptide Synthesis Column...
Biology Products: